[HTML][HTML] Risk-based bioengineering strategies for reliable bacterial vaccine production

T Kamminga, SJ Slagman, VAPM Dos Santos… - Trends in …, 2019 - cell.com
Design of a reliable process for bacterial antigen production requires understanding of and
control over critical process parameters. Current methods for process design use extensive …

Nondestructive quantitative inspection of drug products using benchtop NMR relaxometry—the case of NovoMix® 30

KT Briggs, MB Taraban, W Wang, YB Yu - AAPS PharmSciTech, 2019 - Springer
Batch-level inference-based quality control is the standard practice for drug products.
However, rare drug product defects may be missed by batch-level statistical sampling …

Implementation of QbD for the development of a vaccine candidate

J Haas, A Franklin, M Houser, D Maraldo, M Mikola… - Vaccine, 2014 - Elsevier
This case study provides an example of how Quality by Design (QbD) principles were
applied to accelerate process development to manufacture a vaccine candidate at …

An adjuvant-modulated vaccine response in human whole blood

J Hakimi, A Azizi, SF Ausar, SM Todryk… - Human Vaccines & …, 2017 - Taylor & Francis
The restimulation of an immune memory response by in vitro culture of blood cells with a
specific antigen has been used as a way to gauge immunity to vaccines for decades. In this …

[HTML][HTML] Building a business case for biopharmaceutical qbd implementation (peer reviewed)

B Junker - BioPharm International, 2012 - biopharminternational.com
The aim of this paper is to describe a methodology for developing a per product qualitative
and semi-quantitative business case for application of quality-by-design (QbD) for a …

Quality by Design in Bioanalytics

J Jacyna, M Kordalewska, MJ Markuszewski - Handbook of Bioanalytics, 2022 - Springer
Quality by design (QbD) is frequently implemented during product development nowadays. It
allows to optimize the production process in a way such that the obtained product has the …

[BOOK][B] Systems Analysis of Mycoplasma Hyopneumoniae to Improve Vaccine Production

T Kamminga - 2017 - search.proquest.com
Mycoplasma hyopneumoniae (M. hyopneumoniae) is a bacterial pathogen that has evolved
from a gram-positive ancestor and specifically colonizes the lower respiratory tract of pigs …

Entwicklung eines Simulationsmodells für das Life-Cycle-Management von Arzneimitteln

S Trebbien - 2016 - openscience.ub.uni-mainz.de
Das Life-Cycle-Management (LCM) ist in vielen industriellen Bereichen schon lange ein
gängiges Verfahren zur Planung, Überwachung und Optimierung der Herstellung und des …

[CITATION][C] Cell Culture Technologies in Successful Biosimilar Development

J Yuan, WW Xu, HX Yu, LY Jiang, HF Poon - Bioequivalence Bioavailab Int J, 2018